Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 13, 2015
Weight Supplement Containing Drugs Recalled
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective." Recalled UltraZx is packaged in bottles containing thirty 300 mg capsules, and was distributed between September 2014 and February 2015.
Consumers who have purchased UltraZx should not use it, but return the product to UltraZx Labs, and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more about this recall, use the link below.